ISRCTN15363958已完成2 期
Multicenter, randomized, double-blind study with placebo to verify the efficacy, safety and tolerability of the modified isothymol or carvacrol compound against the SARS-CoV-2 agent in COVID-19 patients
Instituto Venezolano de Investigaciones Científicas0 个研究点目标入组 600 人开始时间: 2022年6月23日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 600
研究概览
简要总结
2021 Results article in http://cesdi.net/campus-virtual/mod/data/view.php?d=1&rid=93 page 151 (added 22/06/2022) 2022 Results article in https://www.longdom.org/abstract/clinical-study-to-verify-the-effectiveness-and-safety-of-the-modified-isothymol-or-carvacrol-compound-against-sarscov2-i-94562.html (added 07/10/2022)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Positive test PDR, positive test RT-PCR, patients diagnosed with COVID-19
- •2. Chest pain or other symptom consistent with bilateral pneumonia atypical, with one of the following paraclinical alterations and imaging:
- •3. Oxygen saturation (SpO2) =93%.
- •4. Elevation of D-dimer =10 mg/mL.
- •5. Elevation of Ferritin =120 ng/mL.
- •6. Elevation of Fibrinogen =400 mg/dL
- •7. Elevation of Immunoglobulin M (IgM) =200 mg/dL.
- •8. Elevation of Interleukin 6 (IL-6) =1800 pg/mL.
- •9. Rx. chest and CT showing thickening of the bronchi, consolidation and ground glass opacities.
排除标准
- •Negative test PDR, negative test RT-PCR and Inadequate administration of antiviral (for non-compliance with indicated intervals or death of the patient before 15 days treatment indications).
研究者
相似试验
已完成
3 期
Effects of ethyl lauroyl arginine nasal spray on COVID-19COVID-19 (SARS-CoV-2 infection)Infections and InfestationsISRCTN17834262Salvacion LLC30
已完成
不适用
Rifaximin to reduce infection in decompensated cirrhosisDigestive SystemDecompensated cirrhosisISRCTN10994757Imperial College London78
进行中（未招募）
不适用
A pilot study to evaluate automatic deep vein thrombosis diagnostic softwareDeep vein thrombosisCirculatory SystemPhlebitis and thrombophlebitis of other deep vessels of lower extremitiesISRCTN11069056Oxford University Hospitals NHS Trust400
已完成
3 期
A multicentre, phase III, randomised, double-blind, placebo-controlled trial of pravastatin added to first-line chemotherapy in patients with small cell lung cancerLung cancerSmall cell lung cancerCancerISRCTN56306957niversity College London (UK)860
已完成
不适用
A multi-centre, randomised, double-blind trial studying the effect of misoprostol on the outcome of intra-uterine inseminatioISRCTN76424181niversity Hospital Ghent (Belgium)217